206 related articles for article (PubMed ID: 11340074)
1. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
Zhu Q; Yao J; Wani G; Wani MA; Wani AA
J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
[TBL] [Abstract][Full Text] [Related]
2. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
4. Stabilization and activation of p53 by the coactivator protein TAFII31.
Buschmann T; Lin Y; Aithmitti N; Fuchs SY; Lu H; Resnick-Silverman L; Manfredi JJ; Ronai Z; Wu X
J Biol Chem; 2001 Apr; 276(17):13852-7. PubMed ID: 11278372
[TBL] [Abstract][Full Text] [Related]
5. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
Grossman SR; Perez M; Kung AL; Joseph M; Mansur C; Xiao ZX; Kumar S; Howley PM; Livingston DM
Mol Cell; 1998 Oct; 2(4):405-15. PubMed ID: 9809062
[TBL] [Abstract][Full Text] [Related]
6. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
Jin Y; Zeng SX; Lee H; Lu H
J Biol Chem; 2004 May; 279(19):20035-43. PubMed ID: 14769800
[TBL] [Abstract][Full Text] [Related]
7. MDM2 suppresses p73 function without promoting p73 degradation.
Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
[TBL] [Abstract][Full Text] [Related]
8. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
Maki CG
J Biol Chem; 1999 Jun; 274(23):16531-5. PubMed ID: 10347217
[TBL] [Abstract][Full Text] [Related]
9. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function.
Thomas A; White E
Genes Dev; 1998 Jul; 12(13):1975-85. PubMed ID: 9649502
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
Nie L; Sasaki M; Maki CG
J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
[TBL] [Abstract][Full Text] [Related]
13. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
[TBL] [Abstract][Full Text] [Related]
15. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.
Yu ZK; Geyer RK; Maki CG
Oncogene; 2000 Nov; 19(51):5892-7. PubMed ID: 11127820
[TBL] [Abstract][Full Text] [Related]
16. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
Wadgaonkar R; Collins T
J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
[TBL] [Abstract][Full Text] [Related]
17. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
Nakamura S; Roth JA; Mukhopadhyay T
Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
[TBL] [Abstract][Full Text] [Related]
18. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
19. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
Knights CD; Liu Y; Appella E; Kulesz-Martin M
J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
[TBL] [Abstract][Full Text] [Related]
20. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]